FINANCIAL ANALYSIS OF WYETH PAKISTAN LIMITED

By: OZAIR ARSHAD

INDEX
1. Introduction 2. History and Profile 3. Key Activities of Wyeth 4. Wyeth Products Profile 5. Data Collection & Market Assessment 6. Main Competitors 7. Share Price in Last 12 Months 8. Shareholding Pattern 9. The Director’s Report 10.The Auditor’s Report 11.Financial Ratios & Analysis 12. Horizontal Analysis a) Income Statement b)Balance Sheet 13. Vertical Analysis a)Balance Sheet b) Income Statement 14. Financial Analysis & Conclusions i) Gross Profit Margin ii) Net Profit Margin iii) Return on Assets iv) DPS & EPS 15. Annexure 16. References

1. Introduction
Wyeth, formerly one of the companies owned by American Home Products Corporation (AHP), is a pharmaceutical company The company was based in Madison, New Jersey, USA. They were known for manufacturing the over-the-counter (OTC) drugs Robitussin and the analgesic Advil (ibuprofen), as well as the prescription drugs Premarin and Effexor, which both boast over US$3 billion in sales annually. Wyeth has multiple subsidiaries in different countries of the world its Pakistan branch is known as Wyeth Pakistan Limited. This is a public limited company incorporated in 1949 in Pakistan. The company is listed on the Karachi and Lahore Stock exchange. The company is engaged in manufacturing and marketing of research based ethical specialties and other pharmaceutical products.

2. History & Profile
Late 18th Century
In 1860, pharmacists John (1834–1907) and Frank Wyeth opened a drugstore with a small research lab on Walnut Street in Philadelphia. In 1862, on the suggestion of doctors, they began to manufacture large quantities of commonly ordered medicines. They were successful, and in 1864 they began supplying medicines and beef extract to the Union army during the Civil War.

19th Century
In 1930, Wyeth purchased Anacin, a product for